Literature DB >> 25404015

Therapy: Low-dose aspirin to reduce the risk of pre-eclampsia?

Baha M Sibai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25404015     DOI： 10.1038/nrendo.2014.199

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

2.  Aspirin for pre-eclampsia: beware of subgroup meta-analysis.

Authors:  S Meher; Z Alfirevic
Journal:  Ultrasound Obstet Gynecol       Date:  2013-05       Impact factor: 7.299

3.  Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

4.  Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  S Caritis; B Sibai; J Hauth; M D Lindheimer; M Klebanoff; E Thom; P VanDorsten; M Landon; R Paul; M Miodovnik; P Meis; G Thurnau
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

Review 5.  Prediction and prevention of recurrent preeclampsia.

Authors:  John R Barton; Baha M Sibai
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

6.  ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group.

Authors: 
Journal:  Br J Obstet Gynaecol       Date:  1996-01

7.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321

Review 8.  Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.

Authors:  Lisa M Askie; Lelia Duley; David J Henderson-Smart; Lesley A Stewart
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321
  8 in total
  5 in total

Review 1.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

Review 2.  Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?

Authors:  Sinuhe Hahn; Olav Lapaire; Nandor Gabor Than
Journal:  Expert Rev Mol Diagn       Date:  2015-03-16       Impact factor: 5.225

Review 3.  Aspirin for Prevention of Preeclampsia.

Authors:  A Atallah; E Lecarpentier; F Goffinet; M Doret-Dion; P Gaucherand; V Tsatsaris
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

4.  Lack of Thromboxane Synthase Prevents Hypertension and Fetal Growth Restriction after High Salt Treatment during Pregnancy.

Authors:  Chen-Hsueh Pai; Ching-Tzu Yen; Chie-Pein Chen; I-Shing Yu; Shu-Wha Lin; Shu-Rung Lin
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

Review 5.  Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy.

Authors:  Suchismita Dutta; Sathish Kumar; Jon Hyett; Carlos Salomon
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.